Dagim Shiferaw Tadele

Dagim Shiferaw Tadele

Auto-generated profile, based on publicly available information

Dagim Shiferaw Tadele

Department of Molecular Genetics, Division of Laboratory Medicine, Oslo University Hospital, Oslo, Norway

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
BTBenedicte Sjo Tislevoll
Benedicte Sjo Tislevoll
MHMonica Hellesøy
Monica Hellesøy
OFOda Helen Eck Fagerholt
Oda Helen Eck Fagerholt
SGStein-Erik Gullaksen
Stein-Erik Gullaksen
ASAashish Srivastava
Aashish Srivastava
BGBjorn T Gjertsen
Bjorn T Gjertsen
Aberrant pro-survival signaling is a hallmark of cancer cells, but the response to chemotherapy is poorly understood. In this study, we investigate the initial signaling response to standard induction chemotherapy in a cohort of 32 acute myeloid leukemia (AML) patients, using 36-dimensional mass cytometry. Through supervised and unsupervised machine learning approaches, we find that reduction of extracellular-signal-regulated kinase (ERK) 1/2 and p38 mitogen-activated protein kinase (MAPK) phosphorylation in the myeloid cell compartment 24 h post-chemotherapy is a significant predictor of patient 5-year overall survival in this cohort. Validation by RNA sequencing shows induction of MAPK target gene expression in patients with high phospho-ERK1/2 24 h post-chemotherapy, while proteomics confirm an increase of the p38 prime target MAPK activated protein kinase 2 (MAPKAPK2). In this study, we demonstrate that mass cytometry can be a valuable tool for early response evaluation in AML and elucidate the potential of functional signaling analyses in precision oncology diagnostics.

3 June 2024 in PRX Life
Verified
Journal Article
Open access
PDF file
JMJeff Maltas
Jeff Maltas
DTDagim Shiferaw Tadele
Dagim Shiferaw Tadele
ADArda Durmaz
Arda Durmaz
CMChristopher D. McFarland
Christopher D. McFarland
MHMichael Hinczewski
Michael Hinczewski
JSJacob G Scott
Jacob G Scott
The evolution of resistance remains one of the primary challenges for modern medicine, from infectious diseases to cancers. Many of these resistance-conferring mutations often carry a substantial fitness cost in the absence of treatment. As a result, we would expect these mutants to undergo purifying selection and be rapidly driven to extinction. Nevertheless, preexisting resistance is frequently observed from drug-resistant malaria to targeted cancer therapies in non-small-cell lung cancer (NSCLC) and melanoma. Solutions to this apparent paradox have taken several forms, from spatial rescue to simple mutation supply arguments. Recently, in an evolved resistant NSCLC cell line, we found that frequency-dependent ecological interactions between ancestor and resistant mutant ameliorate the cost of resistance in the absence of treatment. Here, we hypothesize that frequency-dependent ecological interactions in general play a major role in the prevalence of preexisting resistance. We combine numerical simulations with robust analytical approximations to provide a rigorous mathematical framework for studying the effects of frequency-dependent ecological interactions on the evolutionary dynamics of preexisting resistance. First, we find that ecological interactions significantly expand the parameter regime under which we expect to observe preexisting resistance. Next, even when positive ecological interactions between mutants and ancestors are rare, these resistant clones provide the primary mode of evolved resistance because even weak positive interaction leads to significantly longer extinction times. We then find that even in the case where mutation supply alone is sufficient to predict preexisting resistance, frequency-dependent ecological forces still contribute a strong evolutionary pressure that selects for increasingly positive ecological effects (negative frequency-dependent selection). Finally, we genetically engineer several of the most common clinically observed resistance mechanisms to targeted therapies in NSCLC, a treatment notorious for preexisting resistance. We find that each engineered mutant displays a positive ecological interaction with their ancestor. As a whole, these results suggest that frequency-dependent ecological effects can play a crucial role in shaping the evolutionary dynamics of preexisting resistance. Published by the American Physical Society 2024

5 April 2023 in Journal of Mathematical Biology
Verified
Journal Article
Open access
PDF file
SHSara Hamis
Sara Hamis
PSPanu Somervuo
Panu Somervuo
JÅJ. Arvid Ågren
J. Arvid Ågren
DTDagim Shiferaw Tadele
Dagim Shiferaw Tadele
JKJuha Kesseli
Juha Kesseli
OOOtso Ovaskainen
Otso Ovaskainen
Theoretical and applied cancer studies that use individual-based models (IBMs) have been limited by the lack of a mathematical formulation that enables rigorous analysis of these models. However, spatial cumulant models (SCMs), which have arisen from theoretical ecology, describe population dynamics generated by a specific family of IBMs, namely spatio-temporal point processes (STPPs). SCMs are spatially resolved population models formulated by a system of differential equations that approximate the dynamics of two STPP-generated summary statistics: first-order spatial cumulants (densities), and second-order spatial cumulants (spatial covariances). We exemplify how SCMs can be used in mathematical oncology by modelling theoretical cancer cell populations comprising interacting growth factor-producing and non-producing cells. To formulate model equations, we use computational tools that enable the generation of STPPs, SCMs and mean-field population models (MFPMs) from user-defined model descriptions (Cornell et al. Nat Commun 10:4716, 2019). To calculate and compare STPP, SCM and MFPM-generated summary statistics, we develop an application-agnostic computational pipeline. Our results demonstrate that SCMs can capture STPP-generated population density dynamics, even when MFPMs fail to do so. From both MFPM and SCM equations, we derive treatment-induced death rates required to achieve non-growing cell populations. When testing these treatment strategies in STPP-generated cell populations, our results demonstrate that SCM-informed strategies outperform MFPM-informed strategies in terms of inhibiting population growths. We thus demonstrate that SCMs provide a new framework in which to study cell-cell interactions, and can be used to describe and perturb STPP-generated cell population dynamics. We, therefore, argue that SCMs can be used to increase IBMs’ applicability in cancer research.

16 March 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
RBRowan J Barker-Clarke
Rowan J Barker-Clarke
JPJonathan Asher Pachter
Jonathan Asher Pachter
JGJason M Gray
Jason M Gray
SLSydney Leither
Sydney Leither
MSMaximilian Strobl
Maximilian Strobl
JSJacob G Scott
Jacob G Scott
Evolution underpins the survival of a population under environmental pressure. Resistance to treatment commonly arises as a result of such evolution. We analytically examine the addition of frequency-dependent effects on evolutionary outcomes. Through the lens of experimental biology, we frame these interactions as cell-extrinsic, growth rate-modifying, ecological interactions. Additionally, we show the extent to which the presence of these ecological interactions can modify evolutionary trajectories predicted from cell-intrinsic properties alone and show that these interactions can modify evolution in such ways as to mask or mimic or maintain the results of cell-intrinsic fitness advantages. This work has implications for the interpretation and understanding of evolution, a result which may explain an abundance of apparently neutral evolution in cancer systems and similarly heterogeneous populations. In addition, the derivation of an analytical result for stochastic, ecologically dependent evolution paves the way for treatment approaches involving genetic and ecological control. Author Summary Through analytical and simulation methods we focus on decomposing the cell-intrinsic and cell-extrinsic interactions in a game-theoretic framework for interacting subpopulations in a genetic system. We highlight the ability of extrinsic contributions to arbitrarily alter the evolution of a population of interacting agents. We derive an exact solution to the 1-dimensional Fokker-Planck equation for a two-player genetic system including mutation, selection, drift and games. Examining how the strength of the specific game interactions alters our analytical solution, we validate these theoretical predictions in simulations. We derive expressions for the conditions on the game interactions in this one-dimensional case that mask the cell-intrinsic monoculture landscape dynamics.

6 March 2024 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
CWChenyu Wu
Chenyu Wu
EGEinar Bjarki Gunnarsson
Einar Bjarki Gunnarsson
EMEven Moa Myklebust
Even Moa Myklebust
AKAlvaro Köhn-Luque
Alvaro Köhn-Luque
DTDagim Shiferaw Tadele
Dagim Shiferaw Tadele
KLKevin Leder
Kevin Leder
Tumor heterogeneity is a complex and widely recognized trait that poses significant challenges in developing effective cancer therapies. In particular, many tumors harbor a variety of subpopulations with distinct therapeutic response characteristics. Characterizing this heterogeneity by determining the subpopulation structure within a tumor enables more precise and successful treatment strategies. In our prior work, we developed PhenoPop, a computational framework for unravelling the drug-response subpopulation structure within a tumor from bulk high-throughput drug screening data. However, the deterministic nature of the underlying models driving PhenoPop restricts the model fit and the information it can extract from the data. As an advancement, we propose a stochastic model based on the linear birth-death process to address this limitation. Our model can formulate a dynamic variance along the horizon of the experiment so that the model uses more information from the data to provide a more robust estimation. In addition, the newly proposed model can be readily adapted to situations where the experimental data exhibits a positive time correlation. We test our model on simulated data (in silico) and experimental data (in vitro), which supports our argument about its advantages.

20 January 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
AKAlvaro Köhn-Luque
Alvaro Köhn-Luque
EMEven Moa Myklebust
Even Moa Myklebust
DTDagim Shiferaw Tadele
Dagim Shiferaw Tadele
MGMariaserena Giliberto
Mariaserena Giliberto
LSLeonard Schmiester
Leonard Schmiester
JFJasmine Foo
Jasmine Foo
Tumor heterogeneity is an important driver of tumor recurrence, as treatments that initially elicit clinical responses can select for drug-tolerant tumor subpopulations, leading to the outgrowth of resistant clones and cancer treatment failure. Profiling the drug-response heterogeneity of tumor samples using traditional genomic deconvolution methods has yielded limited results, due in part to the imperfect mapping between genomic variation and functional characteristics. Here, by introducing an underlying population dynamic model of tumor subclonal response to therapy, we enable the phenotypic deconvolution of bulk drug-response data into component subpopulations, and the estimation of their differential drug sensitivities and population frequencies. We used this method, called DECIPHER, to perform deconvolution on tumor drug screening data generated both experimentally and in silico. This study demonstrates how mechanistic population modeling can be leveraged to develop statistical frameworks for profiling phenotypic heterogeneity from bulk tumor samples and to perform individualized patient treatment predictions.